Locations:

Tag: immunotherapy

March 1, 2021/Cancer/Research

New Society Guidelines for Tissue Procurement in Immuno-oncology Clinical Trials

Parameters for the collection and management of biospecimens

20-NEU-2001034_parkinson-disease-immune-response_650x450

November 24, 2020/Basic & Translational Science

Exploring the Role of Immune Response in Parkinson Disease

Research consortium launches multisite investigations of the impact of aberrant immunity

November 2, 2020/Cancer

Holistic and Molecular-Based Approach to Personalized Medicine for Pediatric Brain Tumors

Neurooncology team uses genetic mapping to target treatment

April 24, 2020/COVID-19

Rheumatology, Immunology and COVID-19: The Cytokine Storm and Open Trials

New reviews offer insights on immunotherapies

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

November 7, 2019/Leadership/Leadership Highlights

No. 4 Medical Innovation for 2020: Therapy for Peanut Allergies

Oral immunotherapy drug is first of its kind

August 20, 2019/Cancer

Immunotherapy for Non-Small Cell Lung Cancer Brain Metastases: Ready for Prime Time

Companion studies reveal efficacy indicators for PD-1/PD-L1 inhibition

June 3, 2019/Cancer/Research

Could Immunotherapy Help Cure Cutaneous Squamous Cell Carcinoma?

Enroll patients now in KEYNOTE-630 trial

April 12, 2019/Cancer/Tumor Oncology

Metastatic Non-Clear Cell Renal Cancer Patients Have Positive Response to Immunotherapy

Analysis provides evidence to guide treatment of uncommon RCC subtypes

March 12, 2019/Cancer/Tumor Oncology

Three Treatment Modalities Emerge for Patients with Triple-Negative Breast Cancer

Immunotherapy, PARP inhibitors and a targeted therapy

December 6, 2018/Cancer/Research

Immunosuppressive Therapy Helps Nearly 50 Percent of Patients with Myelodysplastic Syndromes

Study includes largest cohort to date

BackPage 2 of 3Next